Article Details

As Pfizer (PFE) Valuation Declined, Insight 2811 Has Boosted Position by $403725; Crosslink ...

Retrieved on: 2018-06-02 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

As Pfizer (PFE) Valuation Declined, Insight 2811 Has Boosted Position by $403725; Crosslink .... View article details on hiswai:

Excerpt

<div>As Pfizer (PFE) Valuation Declined, Insight 2811 Has Boosted Position by $403,725; <b>Crosslink Capital</b> Holding in Interxion (INXN) Has Trimmed as ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up